MCK
May 8, 2025 - AI Summary
Undervalued by 81.9% based on the discounted cash flow analysis.
Market cap | $90.20 Billion |
---|---|
Enterprise Value | $91.89 Billion |
Dividend Yield | $2.84 (0.393941075292682%) |
Earnings per Share | $25.86 |
Beta | 0.49 |
Outstanding Shares | 125,200,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 27.39 |
---|---|
PEG | 46.2 |
Price to Sales | 0.25 |
Price to Book Ratio | -51.49 |
Enterprise Value to Revenue | 0.26 |
Enterprise Value to EBIT | 21.62 |
Enterprise Value to Net Income | 22 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | -3.56 |
No data
No data
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...